Zevra Therapeutics earnings were -$105.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ZVRA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$35.7M, up 7.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ZVRA reported annual earnings of -$105.5M, with 129.1% growth. The next ZVRA earnings date is May 5, 2025.
What were Zevra Therapeutics's earnings last quarter?
On ZVRA's earnings call on Invalid Date, Zevra Therapeutics (NASDAQ: ZVRA) reported Q4 2024 earnings per share (EPS) of -$0.69, up 27.78% year over year. Total ZVRA earnings for the quarter were -$35.74 million. In the same quarter last year, Zevra Therapeutics's earnings per share (EPS) was -$0.54.
The next ZVRA earnings date is Invalid Date. Add ZVRA to your watchlist to be reminded of Zevra Therapeutics's next earnings date.
What was ZVRA's earnings growth in the past year?
As of Zevra Therapeutics's earnings date in Invalid Date, Zevra Therapeutics's earnings has grown year over year. ZVRA earnings in the past year totalled -$105.51 million.
Is Zevra Therapeutics profitable or losing money?
As of the last Zevra Therapeutics earnings report, Zevra Therapeutics is currently losing money. Zevra Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$105.51 million, a 129.13% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.